Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 May 22:4:e06959.
doi: 10.7554/eLife.06959.

Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs

Irawati Kandela  1 , James Chou  2 , Kartoa Chow  3 ; Reproducibility Project: Cancer Biology
Collaborators, Affiliations

Registered report: Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs

Irawati Kandela et al. Elife. .

Abstract

The Reproducibility Project: Cancer Biology seeks to address growing concerns about reproducibility in scientific research by conducting replications of 50 papers in the field of cancer biology published between 2010 and 2012. This Registered report describes the proposed replication plan of key experiments from 'Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs' by Sugahara and colleagues, published in Science in 2010 (Sugahara et al., 2010). The key experiments being replicated include Figure 2 and Supplemental Figure 9A. In Figure 2, Sugahara and colleagues presented data on the tumor penetrance of doxorubicin (DOX) when co-administered with the peptide iRGD, as well as the effect of co-treatment of DOX and iRGD on tumor weight and cell death. In Supplemental Figure 9A, they tracked body weight of mice treated with DOX and iRGD to provide evidence that iRGD does not increase known DOX toxicity. The Reproducibility Project: Cancer Biology is a collaboration between the Center for Open Science and Science Exchange, and the results of the replications will be published by eLife.

Keywords: Reproducibility Project: Cancer Biology; human; human biology; medicine; methodology; tumor penetrating peptide.

PubMed Disclaimer

Conflict of interest statement

RP:CB: We disclose that EI, FT, JL, and NP are employed by and hold shares in Science Exchange Inc. The experiments presented in this manuscript will be conducted by IK at the Developmental Therapeutics Core and JC at Lifetein, which are Science Exchange labs. The other authors declare that no competing interests exist.

Similar articles

See all similar articles

Cited by

References

    1. Agemy L, Friedmann-Morvinski D, Kotamraju VR, Roth L, Sugahara KN, Girard OM, Mattrey RF, Verma IM, Ruoslahti E. Targeted nanoparticle enhanced proapoptotic peptide as potential therapy for glioblastoma. Proceedings of the National Academy of Sciences of USA. 2011;108:17450–17455. doi: 10.1073/pnas.1114518108. - DOI - PMC - PubMed
    1. Akashi Y, Oda T, Ohara Y, Miyamoto R, Kurokawa T, Hashimoto S, Enomoto T, Yamada K, Satake M, Ohkohchi N. Anticancer effects of gemcitabine are enhanced by co-administered iRGD peptide in murine pancreatic cancer models that overexpressed neuropilin-1. British Journal of Cancer. 2014;110:1481–1487. doi: 10.1038/bjc.2014.49. - DOI - PMC - PubMed
    1. Danhier F, Le Breton A, Préat V. RGD-based strategies to target alpha(v) beta(3) integrin in Cancer therapy and diagnosis. Molecular Pharmaceutics. 2012;9:2961–2973. doi: 10.1021/mp3002733. - DOI - PubMed
    1. Faul F, Erdfelder E, Lang AG, Buchner A. G* Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007;39:175–191. doi: 10.3758/BF03193146. - DOI - PubMed
    1. Feron O. Tumor-penetrating peptides: a shift from magic bullets to magic guns. Science Translational Medicine. 2010;2:34ps26. doi: 10.1126/scitranslmed.3001174. - DOI - PubMed

Publication types

MeSH terms

Grants and funding

The Reproducibility Project: Cancer Biology is funded by the Laura and John Arnold Foundation, provided to the Center for Open Science in collaboration with Science Exchange. The funder had no role in study design or the decision to submit the work for publication.